Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1977 2
1981 2
1982 2
1983 2
1984 2
1985 3
1986 2
1987 3
1988 2
1989 2
1990 10
1991 3
1992 2
1993 4
1994 8
1995 9
1996 7
1997 6
1998 8
1999 8
2000 4
2001 4
2002 11
2003 10
2004 9
2005 16
2006 9
2007 14
2008 16
2009 14
2010 15
2011 7
2012 23
2013 20
2014 16
2015 22
2016 12
2017 15
2018 20
2019 15
2020 12
2021 10
2022 16
2023 16
2024 11
2025 13
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Memantine in moderate-to-severe Alzheimer's disease.
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group. Reisberg B, et al. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128. N Engl J Med. 2003. PMID: 12672860 Free article. Clinical Trial.
Resistance exercise effects on hippocampus subfield volumes and biomarkers of neuroplasticity and neuroinflammation in older adults with low and high risk of mild cognitive impairment: a randomized controlled trial.
Vints WAJ, Šeikinaitė J, Gökçe E, Kušleikienė S, Šarkinaite M, Valatkeviciene K, Česnaitienė VJ, Verbunt J, Levin O, Masiulis N. Vints WAJ, et al. Geroscience. 2024 Aug;46(4):3971-3991. doi: 10.1007/s11357-024-01110-6. Epub 2024 Mar 13. Geroscience. 2024. PMID: 38478179 Free PMC article. Clinical Trial.
Reliability of aspartic acid racemization rate for chronological age estimation-a systematic review and meta-analysis.
Roy J, Jayaraman J, Johnson A. Roy J, et al. Int J Legal Med. 2022 Sep;136(5):1457-1467. doi: 10.1007/s00414-022-02830-0. Epub 2022 May 3. Int J Legal Med. 2022. PMID: 35503573
OBJECTIVE: The biochemical approach of dental age using aspartic acid racemization has been widely reported. The aim of this systematic review was to determine the reliability and accuracy of dental age estimation using aspartic acid racemization rate …
OBJECTIVE: The biochemical approach of dental age using aspartic acid racemization has been widely reported. The aim of this s …
Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial.
Li L, Li R, Qiu Z, Zhu K, Li R, Zhao S, Che J, Guo T, Xu K, Geng T, Liao Y, Pan A, Liu G. Li L, et al. Diabetes Care. 2026 Jan 1;49(1):68-77. doi: 10.2337/dc25-0728. Diabetes Care. 2026. PMID: 40587116 Clinical Trial.
Several key baseline predictors, primarily gut microbes and fecal metabolites, such as N-acetyl-l-aspartic acid, Ruminococcus callidus, and Bifidobacterium adolescentis, were shared for weight and body composition changes during both phases. ...
Several key baseline predictors, primarily gut microbes and fecal metabolites, such as N-acetyl-l-aspartic acid, Rumino …
Clinical effects of low-dose esketamine for anaesthesia induction in the elderly: A randomized controlled trial.
Li J, Wang Z, Wang A, Wang Z. Li J, et al. J Clin Pharm Ther. 2022 Jun;47(6):759-766. doi: 10.1111/jcpt.13604. Epub 2022 Jan 11. J Clin Pharm Ther. 2022. PMID: 35018643 Clinical Trial.
WHAT IS KNOWN AND OBJECTIVE: Esketamine is an N-methyl-D-aspartic acid (NMDA) receptor antagonist, which has stronger sedative and analgesic effects and fewer adverse events than ketamine. ...
WHAT IS KNOWN AND OBJECTIVE: Esketamine is an N-methyl-D-aspartic acid (NMDA) receptor antagonist, which has stronger sedative …
394 results